LEGN
Legend BiotechยทNASDAQ
--
--(--)
--
--(--)
LEGN Profile
Legend Biotech Corporation
A company that develops novel cell therapies for oncology and other indications
Pharmaceutical
05/27/2015
06/05/2020
NASDAQ Stock Exchange
2,600
12-31
Depository Receipts (Ordinary Shares)
2101 Cottontail Lane, Somerset, NJ 08873
--
Legend Biotech Corporation was incorporated in the Cayman Islands as an exempted company on May 27, 2015. The Company is a global clinical-stage biopharmaceutical company dedicated to the discovery and development of novel cell therapies for oncology and other indications, its lead drug candidate LCAR-B38M/JNJ-4528 is a chimeric antigen receptor or CAR, the Company is developing T cell therapies with strategic partners Janssen Biotech, Inc., or Janssen, For the treatment of multiple myeloma or MM.
